Showing results (11-20 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|January 14, 2000
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency dataA Gaedigk, R R Gotschall, N S Forbes, et al.Pharmacogenetics|January 14, 2000
Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicityS A Salama, S Z Abdel-Rahman, C H Sierra-Torres, et al.Pharmacogenetics|January 14, 2000
Characterization of a novel variant (S145C/L311V) of 3alpha-hydroxysteroid/dihydrodiol dehydrogenase in human liverT Kume, H Iwasa, H Shiraishi, et al.Pharmacogenetics|September 7, 2000
Genetic variation in in-vitro cytokine-induced production of nitric oxide by murine peritoneal macrophagesZ Zídek, D Franková, M BoubelíkPharmacogenetics|September 7, 2000
Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumoursS Ramachandran, P R Hoban, F Ichii-Jones, et al.Pharmacogenetics|April 26, 2000
Limitations of dextromethorphan N-demethylation as a measure of CYP3A activityA D Kashuba, A N Nafziger, G L Kearns, et al.Pharmacogenetics|April 26, 2000
Tentative association of the serotonin transporter with schizophrenia and unipolar depression but not with bipolar disorder in Han ChineseW Liu, N Gu, G Feng, et al.Pharmacogenetics|April 26, 2000
The dopamine D2 receptor 5'-flanking variant, -141C Ins/Del, is not associated with reduced dopamine D2 receptor density in vivoT Pohjalainen, K Någren, E K Syvälahti, et al.Pharmacogenetics|May 10, 2000
Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probesD S Streetman, J S Bertino, A N NafzigerPharmacogenetics|May 10, 2000
Genomic organization of the UGT2b gene cluster on human chromosome 4q13M Riedy, J Y Wang, A P Miller, et al.Pageof 83